Trial Outcomes & Findings for Accelerated iTBS in Smoking Cessation (NCT NCT05271175)

NCT ID: NCT05271175

Last Updated: 2022-09-26

Results Overview

Τhe number of cigarettes participants usually smoke before the treatment.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

104 participants

Primary outcome timeframe

Baseline

Results posted on

2022-09-26

Participant Flow

Participant milestones

Participant milestones
Measure
Active TMS & Neutral Videos
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Treatment
STARTED
34
33
37
Treatment
COMPLETED
29
30
30
Treatment
NOT COMPLETED
5
3
7
One Week Follow up
STARTED
29
30
30
One Week Follow up
COMPLETED
19
23
25
One Week Follow up
NOT COMPLETED
10
7
5
One Month Follow up
STARTED
29
30
30
One Month Follow up
COMPLETED
17
23
21
One Month Follow up
NOT COMPLETED
12
7
9
Six Months Follow up
STARTED
29
30
30
Six Months Follow up
COMPLETED
21
28
28
Six Months Follow up
NOT COMPLETED
8
2
2

Reasons for withdrawal

Reasons for withdrawal
Measure
Active TMS & Neutral Videos
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
One Week Follow up
Lost to Follow-up
10
7
5
One Month Follow up
Lost to Follow-up
12
7
9
Six Months Follow up
Lost to Follow-up
8
2
2

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Active TMS & Neutral Videos
n=29 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=30 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Total
n=89 Participants
Total of all reporting groups
Types of cigarettes
Hand-rolled
10 Participants
n=29 Participants
5 Participants
n=30 Participants
5 Participants
n=30 Participants
20 Participants
n=89 Participants
Types of cigarettes
Cigarillos
1 Participants
n=29 Participants
0 Participants
n=30 Participants
0 Participants
n=30 Participants
1 Participants
n=89 Participants
Types of cigarettes
Mixed
2 Participants
n=29 Participants
0 Participants
n=30 Participants
1 Participants
n=30 Participants
3 Participants
n=89 Participants
Years of smoking
23.18 years
STANDARD_DEVIATION 9.82 • n=29 Participants
23.13 years
STANDARD_DEVIATION 13.58 • n=30 Participants
28.73 years
STANDARD_DEVIATION 12.21 • n=30 Participants
25.06 years
STANDARD_DEVIATION 12.17 • n=89 Participants
If ever quitted
No
9 Participants
n=29 Participants
10 Participants
n=30 Participants
11 Participants
n=30 Participants
30 Participants
n=89 Participants
Age, Continuous
46.52 years
STANDARD_DEVIATION 13.05 • n=29 Participants
42.93 years
STANDARD_DEVIATION 14.42 • n=30 Participants
47.43 years
STANDARD_DEVIATION 12.72 • n=30 Participants
45.62 years
STANDARD_DEVIATION 13.42 • n=89 Participants
Sex: Female, Male
Female
7 Participants
n=29 Participants
10 Participants
n=30 Participants
12 Participants
n=30 Participants
29 Participants
n=89 Participants
If ever quitted
Yes
20 Participants
n=29 Participants
20 Participants
n=30 Participants
19 Participants
n=30 Participants
59 Participants
n=89 Participants
Sex: Female, Male
Male
22 Participants
n=29 Participants
20 Participants
n=30 Participants
18 Participants
n=30 Participants
60 Participants
n=89 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Education
14.07 years
STANDARD_DEVIATION 3.95 • n=29 Participants
14.43 years
STANDARD_DEVIATION 3.77 • n=30 Participants
13.60 years
STANDARD_DEVIATION 3.27 • n=30 Participants
14.03 years
STANDARD_DEVIATION 3.65 • n=89 Participants
Occupation
Private employee
13 Participants
n=29 Participants
19 Participants
n=30 Participants
22 Participants
n=30 Participants
54 Participants
n=89 Participants
Occupation
Public employee
7 Participants
n=29 Participants
4 Participants
n=30 Participants
1 Participants
n=30 Participants
12 Participants
n=89 Participants
Occupation
Self-employed / freelancer
5 Participants
n=29 Participants
1 Participants
n=30 Participants
4 Participants
n=30 Participants
10 Participants
n=89 Participants
Occupation
Unemployed
2 Participants
n=29 Participants
1 Participants
n=30 Participants
0 Participants
n=30 Participants
3 Participants
n=89 Participants
Occupation
Retired
2 Participants
n=29 Participants
4 Participants
n=30 Participants
3 Participants
n=30 Participants
9 Participants
n=89 Participants
Occupation
Student
0 Participants
n=29 Participants
1 Participants
n=30 Participants
0 Participants
n=30 Participants
1 Participants
n=89 Participants
Cigarettes per day
27.55 cigarettes/day
STANDARD_DEVIATION 15.37 • n=29 Participants
26.83 cigarettes/day
STANDARD_DEVIATION 12.86 • n=30 Participants
30.00 cigarettes/day
STANDARD_DEVIATION 13.38 • n=30 Participants
28.13 cigarettes/day
STANDARD_DEVIATION 13.80 • n=89 Participants
Types of cigarettes
Normal
16 Participants
n=29 Participants
25 Participants
n=30 Participants
24 Participants
n=30 Participants
65 Participants
n=89 Participants
How many times quitted
0.90 quit attempts
STANDARD_DEVIATION 0.77 • n=29 Participants
1.00 quit attempts
STANDARD_DEVIATION 1.11 • n=30 Participants
1.20 quit attempts
STANDARD_DEVIATION 1.56 • n=30 Participants
1.03 quit attempts
STANDARD_DEVIATION 1.19 • n=89 Participants

PRIMARY outcome

Timeframe: Baseline

Τhe number of cigarettes participants usually smoke before the treatment.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=29 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=30 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Self-reported Nicotine Consumption
27.55 cigarettes/day
Standard Error 15.37
26.83 cigarettes/day
Standard Error 12.86
30.00 cigarettes/day
Standard Error 13.38

PRIMARY outcome

Timeframe: After 1st treatment day

Population: Two participants from the "Active TMS \& Neutral videos" group and three participants from the "Active TMS \& Smoking videos" group were outliers and were therefore excluded from the analyses.

Participants were required to record the number of cigarettes smoked after the completion of the 1st day of treatment until before the first session on the second day of treatment. Participants were asked not to smoke during the breaks of the 4 daily rTMS sessions

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=27 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=27 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Self-reported Nicotine Consumption
8.72 cigarettes/day
Standard Deviation 8.97
8.67 cigarettes/day
Standard Deviation 8.56
10.60 cigarettes/day
Standard Deviation 7.49

PRIMARY outcome

Timeframe: After 2nd treatment day

Participants were required to record the number of cigarettes smoked after the completion of the 2nd day of treatment until before the first session on the 3rd day of treatment. Participants were asked not to smoke during the breaks of the 4 daily rTMS sessions

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=27 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=29 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Self-reported Nicotine Consumption
7.94 cigarettes/day
Standard Deviation 8.13
7.07 cigarettes/day
Standard Deviation 6.43
9.38 cigarettes/day
Standard Deviation 7.90

PRIMARY outcome

Timeframe: After 3rd treatment day

Participants were required to record the number of cigarettes smoked after the completion of the 3rd day of treatment until before the first session on the 4th day of treatment. Participants were asked not to smoke during the breaks of the 4 daily rTMS sessions

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=26 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=26 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Self-reported Nicotine Consumption
5.92 cigarettes/day
Standard Deviation 6.68
7.79 cigarettes/day
Standard Deviation 8.61
8.20 cigarettes/day
Standard Deviation 7.80

PRIMARY outcome

Timeframe: After 4th treatment day

Participants were required to record the number of cigarettes smoked after the completion of the 4th day of treatment until before the first session on the 5th day of treatment . Participants were asked not to smoke during the breaks of the 4 daily rTMS sessions

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=26 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=27 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Self-reported Nicotine Consumption
5.27 cigarettes/day
Standard Deviation 7.51
4.67 cigarettes/day
Standard Deviation 6.50
6.27 cigarettes/day
Standard Deviation 7.84

PRIMARY outcome

Timeframe: Baseline

CO level was measured using the piCO Smokerlyzer breath carbon monoxide meter device prior to the first rTMS session.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=28 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=29 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Carbon Monoxide (CO)- Evaluated Nicotine Consumption
23.64 ppm
Standard Deviation 14.68
17.24 ppm
Standard Deviation 10.17
21.13 ppm
Standard Deviation 9.63

PRIMARY outcome

Timeframe: Day 1

The average of the four CO-levels, measured before each of the four sessions on Day 1.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=29 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=30 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Carbon Monoxide (CO)- Evaluated Nicotine Consumption
19.09 ppm
Standard Error 12.14
14.83 ppm
Standard Error 8.47
17.77 ppm
Standard Error 7.88

PRIMARY outcome

Timeframe: Day 2

The average of the four CO-levels, measured before each of the four sessions on Day 2.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=29 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=30 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Carbon Monoxide (CO)- Evaluated Nicotine Consumption
11.09 ppm
Standard Deviation 9.69
9.94 ppm
Standard Deviation 8.17
11.03 ppm
Standard Deviation 7.50

PRIMARY outcome

Timeframe: Day 3

The average of the four CO-levels, measured before each of the four sessions on Day 3.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=29 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=30 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Carbon Monoxide (CO)- Evaluated Nicotine Consumption
9.98 ppm
Standard Deviation 10.15
9.61 ppm
Standard Deviation 6.63
8.85 ppm
Standard Deviation 6.58

PRIMARY outcome

Timeframe: Day 4

The average of the four CO-levels, measured before each of the four sessions on Day 4.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=29 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=30 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Carbon Monoxide (CO)- Evaluated Nicotine Consumption
8.35 ppm
Standard Deviation 8.44
8.58 ppm
Standard Deviation 6.65
8.89 ppm
Standard Deviation 6.96

PRIMARY outcome

Timeframe: Day 5

The average of the four CO-levels, measured before each of the four sessions on Day 5.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=29 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=30 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Carbon Monoxide (CO)- Evaluated Nicotine Consumption
8.98 ppm
Standard Deviation 9.68
8.03 ppm
Standard Deviation 7.27
8.18 ppm
Standard Deviation 7.02

PRIMARY outcome

Timeframe: Baseline

Fagerström test for Nicotine Dependence (FTND) is a short, self-report measure that assesses nicotine dependence. It contains six questions, and the total score is calculated as a sum of these six questions. The scores vary from 0 to 10, with lower scores indicating lower dependence on nicotine.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=29 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=30 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Nicotine Dependence
5.86 score on a scale
Standard Deviation 2.26
6.03 score on a scale
Standard Deviation 2.37
6.77 score on a scale
Standard Deviation 2.27

PRIMARY outcome

Timeframe: End of the treatment (On the fifth day, after completing 20 TMS sessions)

Fagerström test for Nicotine Dependence (FTND) is a short, self-report measure that assesses nicotine dependence. It contains six questions, and the total score is calculated as a sum of these six questions. The scores vary from 0 to 10, with lower scores indicating lower dependence on nicotine.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=29 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=30 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Nicotine Dependence
2.31 score on a scale
Standard Deviation 2.62
2.03 score on a scale
Standard Deviation 2.08
2.57 score on a scale
Standard Deviation 2.69

PRIMARY outcome

Timeframe: 1 week follow up

Fagerström test for Nicotine Dependence (FTND) is a short, self-report measure that assesses nicotine dependence. It contains six questions, and the total score is calculated as a sum of these six questions. The scores vary from 0 to 10, with lower scores indicating lower dependence on nicotine.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=19 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=23 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=25 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Nicotine Dependence
1.79 score on a scale
Standard Deviation 1.55
2.04 score on a scale
Standard Deviation 2.49
2.64 score on a scale
Standard Deviation 2.41

PRIMARY outcome

Timeframe: 1 month follow up

Fagerström test for Nicotine Dependence (FTND) is a short, self-report measure that assesses nicotine dependence. It contains six questions, and the total score is calculated as a sum of these six questions. The scores vary from 0 to 10, with lower scores indicating lower dependence on nicotine.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=17 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=23 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=21 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Nicotine Dependence
3.35 score on a scale
Standard Deviation 1.97
2.78 score on a scale
Standard Deviation 2.80
3.38 score on a scale
Standard Deviation 2.84

PRIMARY outcome

Timeframe: 6 months follow up

Fagerström test for Nicotine Dependence (FTND) is a short, self-report measure that assesses nicotine dependence. It contains six questions, and the total score is calculated as a sum of these six questions. The scores vary from 0 to 10, with lower scores indicating lower dependence on nicotine.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=21 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=28 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=28 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Nicotine Dependence
3.71 score on a scale
Standard Deviation 2.43
3.32 score on a scale
Standard Deviation 2.74
3.96 score on a scale
Standard Deviation 2.57

PRIMARY outcome

Timeframe: Baseline

The Visual Analogue Scale (VAS) is a psychometric measurement instrument that measures symptom severity on a continuous scale. The VAS can be quickly and repeatedly administered between tasks and it has been used extensively in smoking research with TMS. We used the VAS to assess smoking craving by asking participants to respond to the question "How much do you want to smoke right now?", on a scale from 0 "no craving" to 100 "most craving ever experienced" by choosing a response on a visual scale given in front of them on a tablet.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=29 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=30 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Momentary Craving
24.21 score on a scale
Standard Deviation 30.64
30.87 score on a scale
Standard Deviation 28.63
25.70 score on a scale
Standard Deviation 30.42

PRIMARY outcome

Timeframe: Day 1

The Visual Analogue Scale (VAS) is a psychometric measurement instrument that measures symptom severity on a continuous scale. The VAS can be quickly and repeatedly administered between tasks and it has been used extensively in smoking research with TMS. We used the VAS to assess smoking craving by asking participants to respond to the question "How much do you want to smoke right now?", on a scale from 0 "no craving" to 100 "most craving ever experienced" by choosing a response on a visual scale given in front of them on a tablet. The average of the eight VAS scores, measured prior and post each of the four sessions on Day 1.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=29 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=30 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Momentary Craving
24.55 score on a scale
Standard Deviation 20.66
33.13 score on a scale
Standard Deviation 22.12
29.03 score on a scale
Standard Deviation 28.59

PRIMARY outcome

Timeframe: Day 2

The Visual Analogue Scale (VAS) is a psychometric measurement instrument that measures symptom severity on a continuous scale. The VAS can be quickly and repeatedly administered between tasks and it has been used extensively in smoking research with TMS. We used the VAS to assess smoking craving by asking participants to respond to the question "How much do you want to smoke right now?", on a scale from 0 "no craving" to 100 "most craving ever experienced" by choosing a response on a visual scale given in front of them on a tablet. The average of the eight VAS scores, measured prior and post each of the four sessions on Day 2.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=29 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=30 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Momentary Craving
15.62 score on a scale
Standard Deviation 16.69
23.54 score on a scale
Standard Deviation 18.88
21.87 score on a scale
Standard Deviation 24.12

PRIMARY outcome

Timeframe: Day 3

The Visual Analogue Scale (VAS) is a psychometric measurement instrument that measures symptom severity on a continuous scale. The VAS can be quickly and repeatedly administered between tasks and it has been used extensively in smoking research with TMS. We used the VAS to assess smoking craving by asking participants to respond to the question "How much do you want to smoke right now?", on a scale from 0 "no craving" to 100 "most craving ever experienced" by choosing a response on a visual scale given in front of them on a tablet. The average of the eight VAS scores, measured prior and post each of the four sessions on Day 3.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=29 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=30 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Momentary Craving
12.45 score on a scale
Standard Deviation 15.33
22.32 score on a scale
Standard Deviation 19.87
17.48 score on a scale
Standard Deviation 21.78

PRIMARY outcome

Timeframe: Day 4

The Visual Analogue Scale (VAS) is a psychometric measurement instrument that measures symptom severity on a continuous scale. The VAS can be quickly and repeatedly administered between tasks and it has been used extensively in smoking research with TMS. We used the VAS to assess smoking craving by asking participants to respond to the question "How much do you want to smoke right now?", on a scale from 0 "no craving" to 100 "most craving ever experienced" by choosing a response on a visual scale given in front of them on a tablet. The average of the eight VAS scores, measured prior and post each of the four sessions on Day 4.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=29 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=30 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Momentary Craving
9.16 score on a scale
Standard Deviation 13.12
20.14 score on a scale
Standard Deviation 18.41
14.44 score on a scale
Standard Deviation 19.18

PRIMARY outcome

Timeframe: Day 5

The Visual Analogue Scale (VAS) is a psychometric measurement instrument that measures symptom severity on a continuous scale. The VAS can be quickly and repeatedly administered between tasks and it has been used extensively in smoking research with TMS. We used the VAS to assess smoking craving by asking participants to respond to the question "How much do you want to smoke right now?", on a scale from 0 "no craving" to 100 "most craving ever experienced" by choosing a response on a visual scale given in front of them on a tablet. The average of the eight VAS scores, measured prior and post each of the four sessions on Day 5.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=29 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=30 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Momentary Craving
10.57 score on a scale
Standard Deviation 15.74
16.08 score on a scale
Standard Deviation 16.14
10.46 score on a scale
Standard Deviation 13.13

PRIMARY outcome

Timeframe: Baseline

Tobacco Craving Questionnaire-Short Form (TCQ-SF) is a self-report measure that assesses tobacco craving in four dimensions. Each factor scale contains three items. TCQ-SF items were rated on a Likert scale of 1 (strongly disagree) to 7 (strongly agree). Total scores vary from 12 to 84, by summing the 12 items and the scores for each factor scale vary from 3 to 21 by summing the three items in each factor scale. A high score indicates high tobacco craving.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=29 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=30 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
General Craving
45.38 Total score
Standard Deviation 17.95
52.03 Total score
Standard Deviation 16.20
43.83 Total score
Standard Deviation 17.25

PRIMARY outcome

Timeframe: End of the treatment (On the fifth day, after completing 20 TMS sessions)

Tobacco Craving Questionnaire-Short Form (TCQ-SF) is a self-report measure that assesses tobacco craving in four dimensions. Each factor scale contains three items. TCQ-SF items were rated on a Likert scale of 1 (strongly disagree) to 7 (strongly agree). Total scores vary from 12 to 84, by summing the 12 items and the scores for each factor scale vary from 3 to 21 by summing the three items in each factor scale. A high score indicates high tobacco craving.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=29 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=30 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
General Craving
30.93 Total score
Standard Deviation 17.05
31.97 Total score
Standard Deviation 14.61
28.63 Total score
Standard Deviation 13.10

PRIMARY outcome

Timeframe: 1 week follow up

Tobacco Craving Questionnaire-Short Form (TCQ-SF) is a self-report measure that assesses tobacco craving in four dimensions. Each factor scale contains three items. TCQ-SF items were rated on a Likert scale of 1 (strongly disagree) to 7 (strongly agree). Total scores vary from 12 to 84, by summing the 12 items and the scores for each factor scale vary from 3 to 21 by summing the three items in each factor scale. A high score indicates high tobacco craving.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=19 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=23 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=25 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
General Craving
29.84 Total score
Standard Deviation 14.18
32.17 Total score
Standard Deviation 21.57
27.28 Total score
Standard Deviation 14.82

PRIMARY outcome

Timeframe: 1 month follow up

Tobacco Craving Questionnaire-Short Form (TCQ-SF) is a self-report measure that assesses tobacco craving in four dimensions. Each factor scale contains three items. TCQ-SF items were rated on a Likert scale of 1 (strongly disagree) to 7 (strongly agree). Total scores vary from 12 to 84, by summing the 12 items and the scores for each factor scale vary from 3 to 21 by summing the three items in each factor scale. A high score indicates high tobacco craving.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=17 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=23 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=21 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
General Craving
37.06 Total score
Standard Deviation 17.94
30.61 Total score
Standard Deviation 19.63
35.24 Total score
Standard Deviation 20.63

PRIMARY outcome

Timeframe: 6 months follow up

Tobacco Craving Questionnaire-Short Form (TCQ-SF) is a self-report measure that assesses tobacco craving in four dimensions. Each factor scale contains three items. TCQ-SF items were rated on a Likert scale of 1 (strongly disagree) to 7 (strongly agree). Total scores vary from 12 to 84, by summing the 12 items and the scores for each factor scale vary from 3 to 21 by summing the three items in each factor scale. A high score indicates high tobacco craving.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=21 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=28 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=28 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
General Craving
51.52 Total score
Standard Deviation 19.50
38.32 Total score
Standard Deviation 18.22
44.68 Total score
Standard Deviation 22.34

SECONDARY outcome

Timeframe: Baseline

Perceived Stress Scale-4 (PSS-4) is a self-report measure that is used to assess psychological stress. PSS-4 items were rated on a Likert scale, ranging from 0 to 4, with those on the positive subscale scored in reverse and the total score was calculated as a sum of these items. The scores vary from 0-16, with a higher score indicating higher perceived stress.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=29 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=30 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Perceived Stress
5.97 score on a scale
Standard Deviation 2.18
6.53 score on a scale
Standard Deviation 2.40
5.60 score on a scale
Standard Deviation 1.98

SECONDARY outcome

Timeframe: End of the treatment (On the fifth day, after completing 20 TMS sessions)

Perceived Stress Scale-4 (PSS-4) is a self-report measure that is used to assess psychological stress. PSS-4 items were rated on a Likert scale, ranging from 0 to 4, with those on the positive subscale scored in reverse and the total score was calculated as a sum of these items. The scores vary from 0-16, with a higher score indicating higher perceived stress.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=29 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=30 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Perceived Stress
5.21 score on a scale
Standard Deviation 2.47
5.90 score on a scale
Standard Deviation 2.34
4.60 score on a scale
Standard Deviation 1.96

SECONDARY outcome

Timeframe: 1 week follow up

Perceived Stress Scale-4 (PSS-4) is a self-report measure that is used to assess psychological stress. PSS-4 items were rated on a Likert scale, ranging from 0 to 4, with those on the positive subscale scored in reverse and the total score was calculated as a sum of these items. The scores vary from 0-16, with a higher score indicating higher perceived stress.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=19 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=23 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=25 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Perceived Stress
4.42 score on a scale
Standard Deviation 2.59
6.00 score on a scale
Standard Deviation 2.66
4.76 score on a scale
Standard Deviation 2.35

SECONDARY outcome

Timeframe: 1 month follow up

Perceived Stress Scale-4 (PSS-4) is a self-report measure that is used to assess psychological stress. PSS-4 items were rated on a Likert scale, ranging from 0 to 4, with those on the positive subscale scored in reverse and the total score was calculated as a sum of these items. The scores vary from 0-16, with a higher score indicating higher perceived stress.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=17 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=23 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=21 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Perceived Stress
4.06 score on a scale
Standard Deviation 2.66
5.57 score on a scale
Standard Deviation 2.13
3.52 score on a scale
Standard Deviation 2.48

SECONDARY outcome

Timeframe: 6 months follow up

Perceived Stress Scale-4 (PSS-4) is a self-report measure that is used to assess psychological stress. PSS-4 items were rated on a Likert scale, ranging from 0 to 4, with those on the positive subscale scored in reverse and the total score was calculated as a sum of these items. The scores vary from 0-16, with a higher score indicating higher perceived stress.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=21 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=28 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=28 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Perceived Stress
4.67 score on a scale
Standard Deviation 1.88
5.75 score on a scale
Standard Deviation 2.05
4.75 score on a scale
Standard Deviation 2.52

SECONDARY outcome

Timeframe: Baseline

Participants were asked to estimate how motivated they were to quit smoking from 0% to 100%. Τhe possible answers were: 0%, 25%, 50%, 75% and 100%. Higher values reflect greater motivation to quit smoking.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=27 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=27 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Motivation to Quit Smoking
77.78 score on a scale
Standard Deviation 21.18
82.41 score on a scale
Standard Deviation 18.10
80.83 score on a scale
Standard Deviation 20.43

SECONDARY outcome

Timeframe: End of the treatment (On the fifth day, after completing 20 TMS sessions)

Participants were asked to estimate how motivated they were to quit smoking from 0% to 100%. Τhe possible answers were: 0%, 25%, 50%, 75% and 100%. Higher values reflect greater motivation to quit smoking.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=27 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=27 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Motivation to Quit Smoking
82.41 score on a scale
Standard Deviation 20.59
84.26 score on a scale
Standard Deviation 19.79
80.83 score on a scale
Standard Deviation 23.38

SECONDARY outcome

Timeframe: 1 week follow up

Participants were asked to estimate how motivated they were to quit smoking from 0% to 100%. Τhe possible answers were: 0%, 25%, 50%, 75% and 100%. Higher values reflect greater motivation to quit smoking.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=19 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=23 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=25 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Motivation to Quit Smoking
72.37 score on a scale
Standard Deviation 23.41
77.17 score on a scale
Standard Deviation 30.07
75.00 score on a scale
Standard Deviation 27.95

SECONDARY outcome

Timeframe: 1 month follow up

Participants were asked to estimate how motivated they were to quit smoking from 0% to 100%. Τhe possible answers were: 0%, 25%, 50%, 75% and 100%. Higher values reflect greater motivation to quit smoking.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=17 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=23 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=21 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Motivation to Quit Smoking
47.06 score on a scale
Standard Deviation 31.72
70.65 score on a scale
Standard Deviation 37.43
52.38 score on a scale
Standard Deviation 38.65

SECONDARY outcome

Timeframe: 6 months follow up

Participants were asked to estimate how motivated they were to quit smoking from 0% to 100%. Τhe possible answers were: 0%, 25%, 50%, 75% and 100%. Higher values reflect greater motivation to quit smoking.

Outcome measures

Outcome measures
Measure
Active TMS & Neutral Videos
n=21 Participants
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=28 Participants
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=28 Participants
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
Motivation to Quit Smoking
41.67 score on a scale
Standard Deviation 34.76
67.86 score on a scale
Standard Deviation 32.53
52.68 score on a scale
Standard Deviation 34.92

Adverse Events

Active TMS & Neutral Videos

Serious events: 0 serious events
Other events: 11 other events
Deaths: 0 deaths

Active TMS & Smoking Videos

Serious events: 0 serious events
Other events: 5 other events
Deaths: 0 deaths

Sham TMS & Smoking Videos

Serious events: 0 serious events
Other events: 7 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Active TMS & Neutral Videos
n=29 participants at risk
Received active iTBS stimulation while watching neutral videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Active TMS & Smoking Videos
n=30 participants at risk
Received active iTBS stimulation while watching smoking-related videos Active intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil.
Sham TMS & Smoking Videos
n=30 participants at risk
Received sham stimulation while watching smoking-related videos Sham intermittent theta burst stimulation: An accelerated iTBS (aiTBS) treatment (4 sessions with 30 minutes break between them) was administered daily for a 5-day period over the left DLPFC using the MagVenture Cool-B65 Active/Placebo (A/P) coil. The MagVenture Cool-B65 Active/Placebo (A/P) coil is designed to support true "double blinded" clinical trials as it can produce active and placebo stimulation by flipping the coil and can mimic tapping sensation during placebo condition During the sham condition, the coil produced the same sound as the real active condition but did not deliver any stimulation on the side of the participant's skull.
General disorders
Mild headache
6.9%
2/29 • Number of events 2 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
13.3%
4/30 • Number of events 4 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
3.3%
1/30 • Number of events 1 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
General disorders
Sleepiness
10.3%
3/29 • Number of events 3 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
0.00%
0/30 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
6.7%
2/30 • Number of events 2 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
General disorders
Insomnia
3.4%
1/29 • Number of events 1 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
0.00%
0/30 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
3.3%
1/30 • Number of events 1 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
General disorders
Nausea
0.00%
0/29 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
0.00%
0/30 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
3.3%
1/30 • Number of events 1 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
General disorders
Numbness on stimulation site
3.4%
1/29 • Number of events 1 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
0.00%
0/30 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
0.00%
0/30 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
General disorders
Tension
3.4%
1/29 • Number of events 1 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
0.00%
0/30 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
3.3%
1/30 • Number of events 1 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
General disorders
Lightheadedness
0.00%
0/29 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
3.3%
1/30 • Number of events 1 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
0.00%
0/30 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
General disorders
Coghiness
3.4%
1/29 • Number of events 1 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
0.00%
0/30 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
0.00%
0/30 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
General disorders
Numbness on stimulation site & Forgetfulness
0.00%
0/29 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
0.00%
0/30 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
3.3%
1/30 • Number of events 1 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
General disorders
Numbness on stimulation site & Sleepiness
3.4%
1/29 • Number of events 1 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
0.00%
0/30 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
0.00%
0/30 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
General disorders
Mild headache & Sleepiness
3.4%
1/29 • Number of events 1 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
0.00%
0/30 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.
0.00%
0/30 • 1 week
Participants were asked to daily report (during the 5-day treatment period) the adverse events they may have had experienced.

Additional Information

Georgios Mikellides

Cyprus rTMS

Phone: 0035799430330

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place